CureApp Satellite Session Present at the 17th World Conference on Tobacco or Health
CureApp Satellite Session Present at the 17th Worl...
Startup Grind : Booth Exhibition & Quickfire pitch
【Our 2ndDay at Startup Grind】On our 2ndday at Startup Grind, we had an...
At Startup Grind: Pitch Bootcamp & Opening NIght
As a Top 50 company at Startup Grind's Global Conference 2018, today w...
CureApp Announces Results from World’s First Randomized Control Study for Digital Therapeutic Smoking Cessation App
Tokyo, Japan – May 30...
CureApp Inc., developing “Digital Therapeutics ”, starts joint-development and clinical research of Digital Therapeutics for hypertension with Jichi Medical University.
CureApp Inc. (head office: Chuo-ku, Tokyo, President and CEO: Kota Sat...
CureApp and its “Digital Therapeutics”, together with NASH (Non-Alcoholic Steatohepatitis) have launched multi-center clinical trials of their Digital Therapeutics.
CureApp and its “Digital Therapeutics︎︎”, together with NASH (Non-Alco...